Postprandial Blood Cell Transcriptome of Normal Weight and Obese Subjects to 3 Caloric Doses of a High-fat Meal
NCT ID: NCT01995110
Last Updated: 2014-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2011-03-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ingestion of Lipids and Changes in Cerebral Blood Flow of People With Obesity
NCT02079116
The Belly Fat Study: Nutritional Intervention to Improve Metabolic Health in Subjects With Increased Abdominal Adiposity
NCT02194504
Metabolism Associated With Abdominal Fat Mass Distribution
NCT01726647
Study of the Mechanisms of Metabolic Adaptations to Overfeeding
NCT02225457
Nutrigenetic Intervention on Blood Lipid Markers and Body Composition of Adults With Overweight and Obesity
NCT05210023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normal weight subjects
high-fat meal A
high-fat meal B
high-fat meal C
obese subjects
high-fat meal A
high-fat meal B
high-fat meal C
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
high-fat meal A
high-fat meal B
high-fat meal C
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 20\<BMI\>25
* waist circumference \<94cm
* age 25-50
* 30\<BMI\>40
* waist circumference \>102cm
Exclusion Criteria
* allergies to food or intolerance to high-fat meal
* vegetarians, vegans
* chronic intake of drugs
* smokers
* diabetes mellitus type I and II
* debiliating kidney disease
* debiliating liver disease
* clinically established coronary heart diseases
* ingestion of vitamins or dietary supplements during the course of the study
25 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agroscope Liebefeld-Posieux Research Station ALP
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guy Vergeres, PhD
Role: PRINCIPAL_INVESTIGATOR
Agroscope Liebefeld-Posieux Research Station ALP
Doreen Gille, M.Sc.
Role: STUDY_DIRECTOR
Agroscope Liebefeld-Posieux Research Station ALP
Kurt Laederach, MD
Role: STUDY_DIRECTOR
Inselspital University of Berne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Agroscope
Bern, Canton of Bern, Switzerland
University Hospital Inselspital Berne
Bern, Canton of Bern, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NUTRICHIP-1-transcriptome
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.